MAIA
MAIA Biotechnology, Inc.
1W: -4.6%
1M: -29.8%
3M: +27.0%
YTD: -8.8%
1Y: -16.6%
3Y: -60.8%
$1.46
-0.04 (-2.67%)
After Hours: $1.44 (-0.02, -1.71%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$54.1M
52W Range0.87-3.19
Volume568,650
Avg Volume1,069,957
Beta-0.02
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOVlad Vitoc
Employees13
SectorHealthcare
IndustryBiotechnology
IPO Date2022-07-28
WebsiteMAIABiotech.com
444 West Lake Street
Chicago, IL 60606
US
Chicago, IL 60606
US
312 416 8592
About MAIA Biotechnology, Inc.
MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded in 2018 and is headquartered in Chicago, Illinois.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Louie Ngar Yee | A-Award | 29,789 | $1.53 | 2025-12-31 |
| Guerrero Ramiro | A-Award | 24,060 | $1.53 | 2025-12-31 |
| CHAOUKI STEVEN M | A-Award | 24,633 | $1.53 | 2025-12-31 |
| Theagene Jean-Manass | A-Award | 24,060 | $1.53 | 2025-12-31 |
| Smith Stan | A-Award | 29,216 | $1.53 | 2025-12-31 |